365 related articles for article (PubMed ID: 17138467)
1. Patients' willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultations.
Barner JC; Branvold A
Res Social Adm Pharm; 2005 Mar; 1(1):77-100. PubMed ID: 17138467
[TBL] [Abstract][Full Text] [Related]
2. Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy consultations.
Branvold A; Barner JC
Int J Pharm Compd; 2003; 7(6):490-4. PubMed ID: 23979811
[TBL] [Abstract][Full Text] [Related]
3. Identifying factors that affect patients' willingness to pay for inhaled insulin.
Pinto SL; Holiday-Goodman M; Black CD; Lesch D
Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
[TBL] [Abstract][Full Text] [Related]
4. Patient valuation of pharmacist services for self care with OTC medications.
Hong SH; Spadaro D; West D; Tak SH
J Clin Pharm Ther; 2005 Jun; 30(3):193-9. PubMed ID: 15896235
[TBL] [Abstract][Full Text] [Related]
5. Physicians' perceptions towards the impact of and willingness to pay for clinical computerization in Hong Kong.
Leung GM; Yeung RY; Lai TY; Johnston JM; Tin KY; Wong IO; Woo PP; Ho LM
Int J Med Inform; 2004 Jun; 73(5):403-14. PubMed ID: 15171982
[TBL] [Abstract][Full Text] [Related]
6. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
[TBL] [Abstract][Full Text] [Related]
7. Consumers' willingness to pay for pharmacy services that reduce risk of medication-related problems.
Suh DC
J Am Pharm Assoc (Wash); 2000; 40(6):818-27. PubMed ID: 11111362
[TBL] [Abstract][Full Text] [Related]
8. An assessment of the burden of migraine using the willingness to pay model.
Hamelsky SW; Lipton RB; Stewart WF
Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
[TBL] [Abstract][Full Text] [Related]
9. Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study.
Greenberg D; Bakhai A; Neumann PJ; Cohen DJ
Health Policy; 2004 Nov; 70(2):207-16. PubMed ID: 15364150
[TBL] [Abstract][Full Text] [Related]
10. Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?
Worley MM; Schommer JC; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL
Res Social Adm Pharm; 2007 Mar; 3(1):47-69. PubMed ID: 17350557
[TBL] [Abstract][Full Text] [Related]
11. Valuing the benefits of a health intervention using three different approaches to contingent valuation: re-treatment of mosquito bed-nets in Nigeria.
Onwujekwe O; Fox-Rushby J; Hanson K
J Health Serv Res Policy; 2004 Apr; 9(2):67-75. PubMed ID: 15099453
[TBL] [Abstract][Full Text] [Related]
12. Patients' satisfaction and their perception of the pharmacist.
Ried LD; Wang F; Young H; Awiphan R
J Am Pharm Assoc (Wash); 1999; 39(6):835-42; quiz 882-4. PubMed ID: 10609450
[TBL] [Abstract][Full Text] [Related]
13. Willingness-to-pay for community-based insurance in Burkina Faso.
Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
[TBL] [Abstract][Full Text] [Related]
14. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
Hu SW; Holt EW; Husni ME; Qureshi AA
Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
[TBL] [Abstract][Full Text] [Related]
15. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
[TBL] [Abstract][Full Text] [Related]
16. Advice-giving on self-medication: perspectives of community pharmacists and consumers in Singapore.
Chui WK; Li SC
J Clin Pharm Ther; 2005 Jun; 30(3):225-31. PubMed ID: 15896239
[TBL] [Abstract][Full Text] [Related]
17. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
Guimarães C; Marra CA; Colley L; Gill S; Simpson SH; Meneilly GS; Queiroz RH; Lynd LD
Int J Technol Assess Health Care; 2009 Jul; 25(3):359-66. PubMed ID: 19619355
[TBL] [Abstract][Full Text] [Related]
18. Willingness to pay to assess patient preferences for therapy in a Canadian setting.
Marra CA; Frighetto L; Goodfellow AF; Wai AO; Chase ML; Nicol RE; Leong CA; Tomlinson S; Ferreira BM; Jewesson PJ
BMC Health Serv Res; 2005 Jun; 5():43. PubMed ID: 15941474
[TBL] [Abstract][Full Text] [Related]
19. Analysis of willingness to pay for implantable cardioverter-defibrillator therapy.
Nowakowska D; Guertin JR; Liu A; Abrahamowicz M; Lelorier J; Lespérance F; Brophy JM; Rinfret S
Am J Cardiol; 2011 Feb; 107(3):423-7. PubMed ID: 21257009
[TBL] [Abstract][Full Text] [Related]
20. Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan.
Tang CH; Liu JT; Chang CW; Chang WY
Health Policy; 2007 Jul; 82(2):251-62. PubMed ID: 17084480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
